RAPT Therapeutics Inc (RAPT)
7.88
-0.12
(-1.50%)
USD |
NASDAQ |
Apr 24, 12:54
RAPT Therapeutics Price to Book Value: 1.865 for April 24, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 23, 2024 | 1.893 |
| April 22, 2024 | 1.860 |
| April 19, 2024 | 1.882 |
| April 18, 2024 | 1.877 |
| April 17, 2024 | 1.903 |
| April 16, 2024 | 1.924 |
| April 15, 2024 | 2.021 |
| April 12, 2024 | 2.175 |
| April 11, 2024 | 2.220 |
| April 10, 2024 | 2.135 |
| April 09, 2024 | 1.997 |
| April 08, 2024 | 1.969 |
| April 05, 2024 | 1.870 |
| April 04, 2024 | 1.896 |
| April 03, 2024 | 1.978 |
| April 02, 2024 | 1.943 |
| April 01, 2024 | 2.000 |
| March 28, 2024 | 2.125 |
| March 27, 2024 | 2.113 |
| March 26, 2024 | 1.988 |
| March 25, 2024 | 1.957 |
| March 22, 2024 | 1.971 |
| March 21, 2024 | 2.014 |
| March 20, 2024 | 2.054 |
| March 19, 2024 | 2.045 |
| Date | Value |
|---|---|
| March 18, 2024 | 1.971 |
| March 15, 2024 | 2.004 |
| March 14, 2024 | 1.990 |
| March 13, 2024 | 2.031 |
| March 12, 2024 | 1.886 |
| March 11, 2024 | 1.917 |
| March 08, 2024 | 2.149 |
| March 07, 2024 | 2.196 |
| March 06, 2024 | 2.163 |
| March 05, 2024 | 2.054 |
| March 04, 2024 | 2.052 |
| March 01, 2024 | 2.101 |
| February 29, 2024 | 2.005 |
| February 28, 2024 | 2.026 |
| February 27, 2024 | 2.103 |
| February 26, 2024 | 2.204 |
| February 23, 2024 | 2.04 |
| February 22, 2024 | 2.162 |
| February 21, 2024 | 2.382 |
| February 20, 2024 | 1.607 |
| February 16, 2024 | 6.076 |
| February 15, 2024 | 5.975 |
| February 14, 2024 | 5.977 |
| February 13, 2024 | 5.846 |
| February 12, 2024 | 6.188 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.607
Minimum
Feb 20 2024
14.59
Maximum
Jan 27 2020
4.409
Average
3.989
Median
Price to Book Value Benchmarks
| Emergent BioSolutions Inc | 0.1757 |
| Avinger Inc | -- |
| Tonix Pharmaceuticals Holding Corp | 0.1448 |
| Skye Bioscience Inc | -- |
| Axsome Therapeutics Inc | 17.57 |
Price to Book Value Related Metrics
| PS Ratio | 92.98 |
| PEG Ratio | -0.5320 |
| Price | 7.88 |
| Earnings Yield | -38.71% |
| Market Cap | 274.21M |
| PEGY Ratio | -0.5320 |